The recent global monkeypox outbreak brings a sense of deja vu with the Covid pandemic, which included painful swabs, a struggle to find a test, and a long wait for results. But the diseases are different, The Verge reported.
Unlike Covid, monkeypox is not a respiratory disease; And the test of covid targeted the nose and mouth.
Monkeypox, on the other hand, manifests as painful, blister-like sores and other symptoms such as fever and muscle aches. Currently, the disease is detected by swabbing the sores visible during infection.
Monkeypox is “a separate enough” infection, Ben Pinsky, medical co-director for the care trial at Stanford Health Care in the US, was quoted as saying.
He said there is still a lot of work to do to find out whether people are able to successfully heal their wounds, which can be painful or difficult.
In addition, the reliance on lesions means that patients can be tested only after obvious signs of the disease are visible. People who remain asymptomatic – especially those without any sores – will not be able to get tested.
On the other hand, people can get tested for COVID-19 without waiting for any specific symptoms to appear.
“I’m a strong advocate for home testing of diseases, but you have to have the right sample at the right time, and we’re not there yet,” said Paul Yager, a professor in the Department of Bioengineering at the University of Washington. was quoted as saying.
But, the potential of rapid at-home test kits cannot be ignored, the report said.
A small study published in Eurosurveillance in June detected monkeypox virus DNA in the saliva and semen of 12 patients in Spain.
Flow Health, a California company, has also developed a saliva-based molecular test for monkeypox that asks people to spit into a tube and then send the sample for PCR testing.
The test is not authorized or approved by the U.S. Food and Drug Administration, which calls for monkeypox tests to be run on wounds.
The company is sharing its saliva test data with the FDA as the agency investigates to see if it should update its guidance, Flow Health CEO Alex Meshkin told The Verge.
However, there is still much to be done to determine how and when the monkeypox virus appears in different parts of the body during the course of the disease, which will affect how effective and accurate tests that do not use lesions will be . Happen.
For example, if the monkeypox virus is visible in saliva before lesions develop, a saliva-based test may help to characterize the disease sooner. But if it doesn’t, that type of test may not be as useful, the report said.
August 05, 2022 Other New York
Disclaimer: This story is auto-aggregated by a computer program and is not created or edited by FreshersLIVE.Publisher : IANS-media